Boons, E., Nogueira, T. C., Dierckx, T., Menezes, S. M., Jacquemyn, M., Tamir, S., . . . Daelemans, D. (2021). XPO1 inhibitors represent a novel therapeutic option in Adult T-cell Leukemia, triggering p53-mediated caspase-dependent apoptosis. Blood Cancer J.
Citação norma ChicagoBoons, Eline, et al. "XPO1 Inhibitors Represent a Novel Therapeutic Option in Adult T-cell Leukemia, Triggering P53-mediated Caspase-dependent Apoptosis." Blood Cancer J 2021.
Citação norma MLABoons, Eline, et al. "XPO1 Inhibitors Represent a Novel Therapeutic Option in Adult T-cell Leukemia, Triggering P53-mediated Caspase-dependent Apoptosis." Blood Cancer J 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.